BackNKGen Biotech Overview

NKGen Biotech Long Term Debt

Latest long-term debt for NKGN: $11M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$11.28M
↑ 11.20% YoYΔ $1.14M vs prior year quarter

Peer trimmed avg / median

Loading

NKGen Biotech Long Term Debt History

Loading

NKGen Biotech vs. peers: Long Term Debt Comparison

Loading

NKGen Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NKGen Biotech (NKGN) FAQ

As of the most recent data (March 2025), NKGN shows a long-term debt of $11M. That compares with $10M in the prior-year period — up 11.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NKGN's long-term debt is now $11M (was $10M) — a 11.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NKGen Biotech is outperforming or lagging.

Tracking NKGN's long-term debt over time shows whether NKGen Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $10M in the prior-year period — up 11.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has NKGen Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $11M) with ownership activity and broader fundamentals.